OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
5.11
-0.12 (-2.29%)
At close: Oct 30, 2026, 4:00 PM EDT
5.01
-0.10 (-1.96%)
After-hours: Oct 30, 2026, 7:43 PM EDT
OmniAb Market Cap
OmniAb has a market cap or net worth of $745.35 million as of October 30, 2026. It is the 11,679th most valuable company in the world and the 2,442nd biggest in the United States. Its market cap has increased by 252.22% in one year.
Market Cap
745.35M
Enterprise Value
699.27M
1-Year Change
252.22%
Global Rank
Country Rank
#2,442 United States
Category
ChartMarket Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $745.35M, a decrease of -24.93%. That is a compound annual growth rate of -6.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 745.35M | 179.87% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helus Pharma | 774.07M |
| Sana Biotechnology | 769.36M |
| Annexon | 767.80M |
| Ardelyx | 755.04M |
| Ginkgo Bioworks Holdings | 754.88M |
| ArriVent BioPharma | 733.21M |
| Wave Life Sciences | 708.05M |
| Sagimet Biosciences | 703.41M |